Chronic treatment with dapagliflozin protects against mitochondrial dysfunction in the liver of C57BL/6NCrl mice with high-fat diet/streptozotocin-induced diabetes mellitus
Konstantin N. Belosludtsev, Vlada S. Starinets, Maxim N. Belosludtsev, I. B. Mikheeva, Mikhail V. Dubinin, Natalia V. Belosludtseva
Topics & Concepts
DapagliflozinStreptozotocinMitochondrionDiabetes mellitusEndocrinologyInternal medicineBiologyPharmacologyType 2 Diabetes MellitusMedicineBiochemistryPancreatic function and diabetesMetabolism, Diabetes, and CancerDiabetes Treatment and Management